You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our BRAF (BRAF) ELISA Kits

Full name:
V-Raf Murine Sarcoma Viral Oncogene Homolog B1 ELISA Kits (BRAF)
On www.antibodies-online.com are 7 V-Raf Murine Sarcoma Viral Oncogene Homolog B1 (BRAF) ELISA Kits from 6 different suppliers available. Additionally we are shipping BRAF Antibodies (393) and BRAF Proteins (29) and many more products for this protein. A total of 451 BRAF products are currently listed.
Synonyms:
9930012E13Rik, AA120551, AA387315, AA473386, B-raf, B-RAF1, Braf, Braf-2, BRAF1, Braf2, C-RMIL, C87398, C230098H17, D6Ertd631e, HYPT11, NS7, RAFB1, RMIL, sierrabraf, Sm-E, SME
list all ELISA KIts Gene Name GeneID UniProt
BRAF 109880 P28028
BRAF 6635 P62304
BRAF 114486  

Show all species

Show all synonyms

BRAF (BRAF) ELISA Kits by Reactivity

Select your species

More ELISA Kits for BRAF Interaction Partners

Xenopus laevis V-Raf Murine Sarcoma Viral Oncogene Homolog B1 (BRAF) interaction partners

  1. BRAF alternative splicing is differentially regulated in vertebrates. Exon 9b is present in all vertebrates, including Xenopus, but exon 8b is present only in eutherians.

Zebrafish V-Raf Murine Sarcoma Viral Oncogene Homolog B1 (BRAF) interaction partners

  1. Gene expression studies nominated TWIST2 (show TWIST2 ELISA Kits) as a key effector downstream of BRAF.

  2. BRAF alternative splicing is differentially regulated in vertebrates. Exon 9b is present in all vertebrates, including Danio rerio, but exon 8b is present only in eutherians.

  3. BRAF activation is sufficient for f-nevus formation, and is among the primary events in melanoma development.

Chimpanzee V-Raf Murine Sarcoma Viral Oncogene Homolog B1 (BRAF) interaction partners

  1. BRAF alternative splicing is differentially regulated in rodent and primates. Exon 9b is present in vertebrates but exon 8b is present only in eutherians.

Mouse (Murine) V-Raf Murine Sarcoma Viral Oncogene Homolog B1 (BRAF) interaction partners

  1. A- and B-Raf ablation in chondrocytes does not alter skeletal development, whereas ablation of C-Raf decreases hypertrophic chondrocyte apoptosis and impairs vascularization of the growth plate. However, ablation of C-Raf does not impair phosphate-induced ERK1/2 phosphorylation in vitro, but leads to rickets by decreasing VEGF protein stability.

  2. these contrasting signatures precisely match those proposed to confer bias toward Hras (show HRAS ELISA Kits)(CAA61CTA) versus Braf(GTG636GAG) mutations in the original tumor sets. Our findings highlight a novel mechanism whereby exposure history acts through strand-biased mutagenesis to specify activation of preferred oncogenes

  3. these results suggest that the activation of 5-HT1D receptors selectively enhanced IA via the Gbetagamma of the Go-protein, PKA, and the sequential B-Raf (show SNRPE ELISA Kits)-dependent p38 MAPK (show MAPK14 ELISA Kits) signaling cascade.

  4. BRAF V600E inhibition stimulates AMP-activated protein kinase (show PRKAA2 ELISA Kits)-mediated autophagy in colorectal cancer cells.

  5. these data confirm the existence of a negative feedback pathway by which BRAF protein stability is regulated by ERK (show EPHB2 ELISA Kits).

  6. coexpression of BRAF(V600E) and KRAS(G12D) in early tumorigenesis leads to negative selection due to oncogene (show RAB1A ELISA Kits)-induced senescence

  7. findings suggest that targeting ErbB-3 (show ERBB3 ELISA Kits) receptors could represent an effective therapeutic approach in BRAF-V600E mutant colon cancer

  8. Atg7 (show ATG7 ELISA Kits) Overcomes Senescence and Promotes Growth of BrafV600E-Driven Melanoma

  9. Cotargeting is the treatment for mutant RAF (show RAF1 ELISA Kits)/MEK (show MDK ELISA Kits)/ERK (show EPHB2 ELISA Kits) and NF-kB pathways to treat mutant BRAF melanomas.

  10. The CM cell lines, as well as the tumor xenografts and their metastases, were positive for the melanoma markers HMB-45, S100B (show S100B ELISA Kits), and MART-1 (show RTL1 ELISA Kits). Two cell lines and their corresponding xenografts carried a BRAF mutation, the third showed an NRAS (show NRAS ELISA Kits) mutation.

Human V-Raf Murine Sarcoma Viral Oncogene Homolog B1 (BRAF) interaction partners

  1. The patients with traditional serrated adenoma showed KRAS and BRAF mutations in 58.4 and 8.3% of cases, respectively. Mutations of these genes were absent. The study revealed that the subtypes of serrated adenomas substantially differ by sex, age, localization, and molecular genetic characteristics

  2. r-BRAF are very uncommon in papillary thyroid carcinomas (PTC (show F9 ELISA Kits)) and are found almost exclusively in PTC (show F9 ELISA Kits) with low-risk clinicopathological features.

  3. (V600)BRAF switches on a metabolic reprogramming in melanoma cells, leading to a decreased OXPHOS activity and increased glycolytic ATP, lactate, HIF-1alpha (show HIF1A ELISA Kits) and MCT4 levels.

  4. Data show that the expression of Interleukin-8 (IL-8 (show IL8 ELISA Kits)) and connective tissue growth factor (CTGF (show CTGF ELISA Kits)) was significantly reduced by treatment with vemurafenib and trametinib in (V600E)BRAF protein melanoma cells.

  5. The authors find that the interaction between sB-Raf (show RAF1 ELISA Kits) and the Hsp90 chaperone (show HSP90 ELISA Kits) system is based on contacts with the M domain of Hsp90 (show HSP90 ELISA Kits), which contributes in forming the ternary complex with Cdc37 (show CDC37 ELISA Kits) as long as the kinase is not stabilized by nucleotide.

  6. Data show that BRAF inhibitor (BRAFi) treatment failed to affect Nodal protein levels in melanoma tissues.

  7. BRAF V600E mutation is associated with cerebellar pilocytic astrocytoma recurring as a ganglioglioma.

  8. findings suggest an association of BRAF-V600E with parameters of a more aggressive behaviour of ameloblastoma

  9. Dabrafenib showed clinical activity in BRAF(V600E)-positive NSCLC. Our findings suggest that dabrafenib could represent a treatment option for a population of patients with limited therapeutic options

  10. BRAF(V600E)-mediated MEK (show MAP2K1 ELISA Kits)/ERK (show EPHB2 ELISA Kits) activation can upregulate MCL-1 (show MCL1 ELISA Kits) by phosphorylation/stabilization to confer apoptosis resistance that can be reversed by MCL-1 (show MCL1 ELISA Kits) antagonism combined with cobimetinib, suggesting a novel therapeutic strategy against BRAF(V600E)-mutant CRCs.

Horse (Equine) V-Raf Murine Sarcoma Viral Oncogene Homolog B1 (BRAF) interaction partners

  1. BRAF alternative splicing is differentially regulated in rodent and primates. Exon 9b is present in vertebrates but exon 8b is present only in eutherians.

BRAF Antigen Profile

Antigen Summary

This gene encodes a protein belonging to the raf/mil family of serine/threonine protein kinases. This protein plays a role in regulating the MAP kinase/ERKs signaling pathway, which affects cell division, differentiation, and secretion. Mutations in this gene are associated with cardiofaciocutaneous syndrome, a disease characterized by heart defects, mental retardation and a distinctive facial appearance. Mutations in this gene have also been associated with various cancers, including non-Hodgkin lymphoma, colorectal cancer, malignant melanoma, thyroid carcinoma, non-small cell lung carcinoma, and adenocarcinoma of lung. A pseudogene, which is located on chromosome X, has been identified for this gene.

Alternative names and synonyms associated with BRAF

  • v-raf murine sarcoma viral oncogene homolog B (braf) Elisa Kit
  • v-raf murine sarcoma viral oncogene homolog B1 (braf) Elisa Kit
  • v-raf murine sarcoma viral oncogene homolog B1 (BRAF) Elisa Kit
  • v-raf murine sarcoma viral oncogene homolog B1 (LOC100219601) Elisa Kit
  • Braf transforming gene (Braf) Elisa Kit
  • Braf transforming gene, related sequence 1 (Braf-rs1) Elisa Kit
  • small nuclear ribonucleoprotein polypeptide E (SNRPE) Elisa Kit
  • v-raf murine sarcoma viral oncogene homolog B (BRAF) Elisa Kit
  • v-raf murine sarcoma viral oncogene homolog B (Braf) Elisa Kit
  • 9930012E13Rik Elisa Kit
  • AA120551 Elisa Kit
  • AA387315 Elisa Kit
  • AA473386 Elisa Kit
  • B-raf Elisa Kit
  • B-RAF1 Elisa Kit
  • Braf Elisa Kit
  • Braf-2 Elisa Kit
  • BRAF1 Elisa Kit
  • Braf2 Elisa Kit
  • C-RMIL Elisa Kit
  • C87398 Elisa Kit
  • C230098H17 Elisa Kit
  • D6Ertd631e Elisa Kit
  • HYPT11 Elisa Kit
  • NS7 Elisa Kit
  • RAFB1 Elisa Kit
  • RMIL Elisa Kit
  • sierrabraf Elisa Kit
  • Sm-E Elisa Kit
  • SME Elisa Kit

Protein level used designations for BRAF

B-Raf , serine/threonine protein kinase BRAF , v-raf murine sarcoma viral oncogene homolog B1 , serine/threonine-protein kinase B-raf , serine/threonine-protein kinase B-raf-like , B-Raf proto-oncogene serine/threonine-protein kinase (p94) , proto-oncogene B-Raf , sm protein E , small nuclear ribonucleoprotein E , snRNP-E , 94 kDa B-raf protein , murine sarcoma viral (v-raf) oncogene homolog B1 , B-raf protein , B-Raf proto-oncogene serine/threonine-protein kinase , proto-oncogene c-Rmil , rmil serine/threonine-protein kinase , serine/threonine kinase , serine/threonine-protein kinase Rmil

GENE ID SPECIES
398973 Xenopus laevis
403065 Danio rerio
463781 Pan troglodytes
100219601 Taeniopygia guttata
100442288 Pongo abelii
109880 Mus musculus
110709 Mus musculus
6635 Homo sapiens
673 Homo sapiens
114486 Rattus norvegicus
536051 Bos taurus
475526 Canis lupus familiaris
396239 Gallus gallus
100065760 Equus caballus
Selected quality suppliers for BRAF (BRAF) ELISA Kits
Did you look for something else?